Efficacy and Safety of TORS for SCCA

Not Applicable

Active, not recruiting

• Conditions: Supraglottic Squamous Cell Carcinoma; Oropharyngeal Squamous Cell Carcinoma

• Registration Number: NCT01819480
• Lead Sponsor: Katherine L Fedder

Brief Summary

The purpose of this study is to learn more about the outcomes of treatment of throat and voice box cancers using transoral robotic surgery (TORS). TORS is a relatively new option involving the use of the da Vinci surgical robot to remove these cancers through the mouth.

Detailed Description

Not available

Study Timeline

• Study Start: 2013-03
• Study First Submitted: 2013-03-22
• Study First Submitted QC: 2013-03-26
• Study First Posted: 2013-03-27
• Status Verified: 2024-02
• Last Update Submitted: 2024-02-07
• Last Update Posted: 2024-02-09
• Primary Completion: 2024-12
• Study Completion: 2025-12

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 110

Inclusion Criteria

• Adult male or female
• Diagnosis of either oropharyngeal or supraglottic squamous cell carcinoma

Exclusion Criteria

• Metastatic disease

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Progression-free survival	3 years	Duration of time from date of surgery to date of recurrence or death

Secondary Outcome Measures

Name	Time	Method
Disease specific survival	3 years	Duration of time from the date of surgery until death with disease present

Trial Locations

Locations (1)

University of Virginia Health System; 🇺🇸 Charlottesville, Virginia, United States